inVentiv Looks To Refi, Fund Deal

inVentiv Health is tapping the loan market for an acquisition and refinancing. UBS and Bank of America lead the facility, which comprises a six-year, $50 million revolver; a seven-year, $330 million first-lien term loan and a seven-year, $20 million delayed-draw term loan. Pricing is LIBOR plus 1 3/4% ...